Cecilie Delphin Amdal

Author information from the last article

Cecilie Delphin Amdal (f. 1969) er leder for PROMiNET ved Avdeling for klinisk forskningsstøtte og overlege i onkologi ved Avdeling for kreftbehandling, Oslo universitetssykehus.

Articles by Cecilie Delphin Amdal

Are surrogate endpoints useful in clinical studies?

Cecilie Delphin Amdal,
Kristin Bjordal

17.06.2014: Surrogate endpoints are often used as measures of therapeutic effect in clinical studies, for example, blood pressure as a risk indicator for cardiovascular disease. Sometimes the presumed association is uncertain. What do we need to be aware of when we interpret the results of such studies, and...